Financial Performance - Net sales for the three months ended March 31, 2025, were $1.368 billion, a slight increase from $1.362 billion in the same period of 2024[366]. - Gross profit decreased to $236 million for the three months ended March 31, 2025, down from $284 million in 2024, reflecting a decline in profitability[366]. - The net loss for the three months ended March 31, 2025, was $4 million, compared to a net income of $54 million in the same period of 2024[366]. - The company recorded a provision for income taxes of $4 million for the three months ended March 31, 2025, down from $16 million in 2024, due to decreased profitability[379]. - For the three months ended March 31, 2025, Chemours utilized supply chain financing to accelerate the collection of $93 million in accounts receivable, compared to $17 million in the same period of 2024[416]. - Chemours experienced a decrease in cash used for operating activities, with $112 million in Q1 2025 compared to $290 million in Q1 2024, primarily due to the unwinding of year-end 2023 net working capital actions[426]. - The net loss attributable to Chemours for the same period was $45 million, compared to a loss before income taxes of $53 million[444]. Cost and Expenses - The cost of goods sold increased by $54 million (or 5%) to $1.132 billion for the three months ended March 31, 2025, primarily due to higher raw materials costs[371]. - Selling, general, and administrative expenses decreased by $14 million (or 10%) to $123 million for the three months ended March 31, 2025, attributed to lower audit-related costs[373]. - Restructuring, asset-related, and other charges rose by $29 million (over 100%) to $33 million for the three months ended March 31, 2025, due to the exit from the SPS Capstone business[375]. - Interest expense increased by $3 million (or 5%) to $66 million for the three months ended March 31, 2025, driven by higher interest rates and increased debt principal[377]. Segment Performance - For the Thermal & Specialized Solutions segment, net sales increased by $12 million (or 3%) to $466 million for the three months ended March 31, 2025, compared to $454 million in the same period in 2024[387]. - Adjusted EBITDA for the Thermal & Specialized Solutions segment decreased by $9 million (or 6%) to $141 million, with an Adjusted EBITDA margin of 30%, down from 33% in the prior year[388]. - The Titanium Technologies segment's net sales increased by $6 million (or 1%) to $597 million for the three months ended March 31, 2025, compared to $591 million in the same period in 2024[394]. - Adjusted EBITDA for the Titanium Technologies segment decreased by $19 million (or 28%) to $50 million, with an Adjusted EBITDA margin of 8%, down from 12% in the prior year[395]. - The Advanced Performance Materials segment's net sales decreased by $9 million (or 3%) to $294 million for the three months ended March 31, 2025, compared to $303 million in the same period in 2024[401]. - Adjusted EBITDA for the Advanced Performance Materials segment increased by $2 million (or 7%) to $32 million, with an Adjusted EBITDA margin of 11%, up from 10% in the prior year[402]. Cash and Liquidity - Total unrestricted cash and cash equivalents as of March 31, 2025, amounted to $464 million, with $291 million held by foreign subsidiaries[412]. - The availability under the Revolving Credit Facility as of March 31, 2025, was $623 million, net of $52 million in outstanding letters of credit[412]. - The company expects liquidity from its sources to adequately support cash needs through at least the end of May 2026[411]. - As of March 31, 2025, Chemours reported unrestricted cash and cash equivalents of $291 million held by foreign subsidiaries, with a net cash outflow of approximately $31 million from the U.S. due to intercompany loans and dividends[418]. - Current liabilities decreased by $144 million (or 8%) to $1.673 billion at March 31, 2025, with accounts payable down by $150 million (or 13%) to $1 billion[436]. - Chemours declared a quarterly cash dividend of $0.0875 per share for Q2 2025, representing a 65% decrease from the previous quarter's dividend, aligning with the company's capital allocation strategy[423]. - Chemours anticipates significant cash payments for contractual obligations over the next 12 months, funded through operations, available cash, and existing debt financing[420]. - The company expects to maintain sufficient liquidity to meet its obligations through at least May 2026, focusing on growth initiatives and returning cash to shareholders[423]. Environmental and Regulatory Matters - The company has accrued litigation costs of $192 million as of March 31, 2025, which includes settlements with Ohio and Delaware[421]. - Environmental remediation liabilities amounted to $567 million as of March 31, 2025, slightly down from $571 million at the end of 2024[458]. - The five most significant environmental remediation sites account for 83% of total accrued liabilities, with expected spending of $128 million over the next three years for these sites[464]. - The New Jersey Department of Environmental Protection (NJ DEP) has mandated a remediation funding source of $943 million for Chambers Works, primarily for non-PFAS remediation[490]. - A conditional fine of up to €3.7 million has been indicated by DCMR for non-compliance with discharge limits, with a grace period until July 2025[474]. - The company has accrued €1 million related to a penalty from the Dutch ILT agency concerning hydrofluorocarbon reporting errors as of March 31, 2025[475]. - The company has implemented improvements to reporting procedures to comply with hydrofluorocarbon regulations after exceeding its quota[475]. - The company has been ordered to meet specific limits for PFAS discharges or face conditional fines, reflecting increased regulatory scrutiny[473]. - The company submitted a revised NPDES permit application in December 2024 to address discharge exceedances and is expected to incur future capital expenditures related to this[487]. - The company is engaged in ongoing legal discussions with four municipalities regarding environmental-related expenditures, with potential losses deemed probable but not estimable at this time[472]. Sustainability Initiatives - Chemours aims for a 60% absolute reduction in greenhouse gas emissions by 2030 and has set a new Scope 3 target to reduce emissions by 25% per ton of product by 2030[492]. - The Opteon™ product portfolio is projected to result in 325 million tons of avoided carbon dioxide equivalent emissions globally by the end of 2025[494]. - A 60% reduction in Scope 1 and Scope 2 absolute GHG emissions has been achieved, along with a 99% reduction in air and water process emissions of fluorinated organic chemicals[495]. - Chemours' Titanium Technologies business is advancing sustainability goals through the Ti-Pure™ Sustainability product series, focusing on climate impact and resource efficiency[498]. Financial Instruments and Hedging - At March 31, 2025, Chemours had 11 foreign currency forward contracts outstanding with a gross notional U.S. dollar equivalent of $185 million[512]. - For the three months ended March 31, 2025, Chemours recognized net losses of $2 million related to non-designated foreign currency forward contracts[512]. - The company has 185 foreign currency forward contracts under a cash flow hedge program with an aggregate notional U.S. dollar equivalent of $201 million as of March 31, 2025[513]. - A pre-tax loss of $15 million was recognized on the net investment hedge for the three months ended March 31, 2025[514]. - The company entered into a cross-currency swap to convert $600 million of senior unsecured notes due January 2033 into €567 million, with a fair value loss of $11 million as of March 31, 2025[515]. - A pre-tax loss of $16 million was recognized for the cross-currency swap for the three months ended March 31, 2025[515]. - The company has two interest rate swaps with an aggregate notional value of $300 million, resulting in a fair value loss of $4 million as of March 31, 2025[517]. - A pre-tax loss of $1 million was recognized for the interest rate swaps for the three months ended March 31, 2025[517]. - The company recognized a pre-tax gain of $4 million from interest rate swaps during the three months ended March 31, 2024[517].

Financial Performance - First quarter 2025 Net Sales were $1.368 billion, consistent with the prior-year quarter, with a 5% increase in volume offset by a 4% decrease in price [4]. - Net Loss attributable to Chemours was $4 million, or $0.03 per diluted share, compared to Net Income of $54 million, or $0.36 per diluted share in the prior-year quarter [5]. - Adjusted EBITDA for Q1 2025 was $166 million, a decrease of 13% from $191 million in the prior-year quarter [4]. - For Q1 2025, Net Sales were reported at $1,368 million, a slight increase from $1,362 million in Q1 2024 [43]. - The Chemours Company reported a net loss of $4 million for the three months ended March 31, 2025, compared to a net income of $54 million in the same period of 2024 [54]. - Adjusted Net Income for the three months ended March 31, 2025, was $19 million, down from $47 million in the previous year [57]. - The estimated Adjusted EBITDA for the year ending December 31, 2025, ranges from $825 million to $950 million [61]. - The company anticipates a net income attributable to Chemours between $168 million and $263 million for the year ending December 31, 2025 [61]. Segment Performance - TSS segment achieved Net Sales of $466 million, a 3% increase year-over-year, driven by a 10% volume increase, while Opteon™ Refrigerants saw a 40% year-over-year growth in Net Sales [11]. - TT segment Net Sales were $597 million, a 1% increase year-over-year, but Adjusted EBITDA decreased 28% to $50 million due to pricing pressures [14]. - APM segment Net Sales decreased 3% to $294 million, with Adjusted EBITDA increasing 7% to $32 million, reflecting lower costs despite unfavorable currency movements [18]. - The Titanium Technologies segment generated net sales of $597 million, a 6% increase compared to $591 million in Q1 2024 [49]. - The Thermal & Specialized Solutions segment reported net sales of $466 million, reflecting a 12% increase from $454 million in Q4 2024 [49]. - The Advanced Performance Materials segment reported net sales of $294 million, a 9% decrease from $303 million in Q1 2024 [49]. Cash Flow and Debt - Cash used for operating activities was $112 million in Q1 2025, a decrease from $290 million in Q1 2024 [54]. - The company’s cash, cash equivalents, restricted cash, and restricted cash equivalents decreased by $249 million to $514 million as of March 31, 2025 [54]. - As of March 31, 2025, consolidated gross debt was $4.1 billion, with a net leverage ratio of approximately 5.0x on a trailing twelve-month Adjusted EBITDA basis [25]. - The net leverage ratio calculated using non-GAAP earnings was 5x as of March 31, 2025, compared to 3.7x in the previous year [53]. - Free Cash Flows for the three months ended March 31, 2025, were negative $196 million, compared to negative $392 million for the same period in 2024 [60]. - Free cash flow conversion is projected to be in the range of 60-80% in the second half of 2025, assuming the current tariff environment remains unchanged [35]. Future Outlook - For Q2 2025, the company anticipates consolidated Net Sales to increase in the low to mid-teens sequentially, with Adjusted EBITDA expected to rise by 40% to 45% [29]. - The Company expects a sequential Net Sales increase in the high single-digits, primarily driven by seasonal volume increases in western markets [33]. - Adjusted EBITDA is anticipated to increase in the low 40% range sequentially due to seasonal volume increases and operational improvements following cold weather downtime at U.S. sites [33]. - For the full year 2025, the Company projects Adjusted EBITDA between $825 million and $950 million, with capital expenditures expected to range from $225 million to $275 million [35]. Corporate Actions - The company signed a manufacturing agreement with Navin Fluorine International, Ltd. for two-phase immersion cooling fluid [9]. - Chemours announced a 65% reduction in its quarterly dividend to $0.0875 per share to enhance balance sheet flexibility [28]. - The Company has approximately 6,000 employees and operates 28 manufacturing sites globally, serving around 2,500 customers in approximately 110 countries [37]. - The Company emphasizes the use of non-GAAP financial measures to provide greater transparency regarding its financial performance and operational decision-making [38]. - The company incurred litigation-related charges of $592 million for the twelve months ended March 31, 2024, primarily related to a class action suit settlement [56]. - Restructuring and other costs for the year ending December 31, 2025, are estimated at $24 million [62].

Company Overview - Chemours (CC) is expected to report a year-over-year decline in earnings, with a projected earnings per share (EPS) of $0.19, reflecting a decrease of 40.6% compared to the previous year [3] - Revenue for the quarter is anticipated to be $1.36 billion, which represents a slight increase of 0.4% from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on May 6, 2025, and the stock price may react positively if the results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 0.87% over the last 30 days, indicating a bearish sentiment among analysts [4] Earnings Surprise Prediction - The Most Accurate Estimate for Chemours is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25.33%, which suggests a challenging outlook for beating the consensus EPS estimate [10][11] - Historically, Chemours has beaten consensus EPS estimates three out of the last four quarters, with a recent surprise of +10% when it reported earnings of $0.11 per share against an expectation of $0.10 [12][13] Industry Comparison - In the Zacks Chemical - Diversified industry, DuPont de Nemours (DD) is expected to report earnings of $0.95 per share, indicating a year-over-year increase of 20.3%, with revenues projected at $3.04 billion, up 3.7% from the previous year [17] - DuPont's consensus EPS estimate has been revised down by 2.4% over the last 30 days, and it currently holds an Earnings ESP of -0.32%, making it difficult to predict a beat against the consensus [18]

Core Insights - Chemours shares have declined approximately 14% since the last earnings report, underperforming the S&P 500 [1] - The consensus estimate for Chemours has decreased by 62.75% over the past month, indicating a negative trend in estimates [2] Financial Performance - The most recent earnings report highlighted a downward trend in estimates, suggesting potential challenges ahead for Chemours [4] - Chemours currently holds a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] Investment Scores - Chemours has a subpar Growth Score of D and a Momentum Score of F, but it received an A for Value, placing it in the top 20% for this investment strategy [3] - The aggregate VGM Score for Chemours is C, which is relevant for investors not focused on a single strategy [3]

Group 1 - The Chemours Company (CC) has formed an alliance with Energy Fuels Inc. to enhance the supply chains for rare earth and critical minerals in response to rising demand [1][2] - Energy Fuels is anticipated to produce large quantities of rare earth elements, titanium ilmenite, and zircon minerals in the upcoming years, while Chemours is involved in mining and separating heavy mineral sands in Florida and Georgia [2] - The collaboration exemplifies the mining industry's commitment to reshoring mineral supply chains and increasing domestic production to satisfy modern society's significant mineral demands [3] Group 2 - Chemours expects its full-year 2025 adjusted EBITDA to be between $825 million and $975 million, with capital expenditures projected between $250 million and $300 million [4] - CC's stock has declined by 46.4% over the past year, compared to a 13.2% decline in the industry [3] - CC currently holds a Zacks Rank of 3 (Hold), while better-ranked stocks in the Basic Materials sector include Ingevity Corporation (NGVT), Axalta Coating Systems (AXTA), and Carpenter Technology Corporation (CRS) [5]

Core Insights - The Chemours Company reported a net loss of $8 million or 5 cents per share for Q4 2024, an improvement from a loss of $18 million or 12 cents in the same quarter last year [1] - Adjusted earnings came in at 11 cents per share, beating the Zacks Consensus Estimate of 10 cents [1] - Fourth-quarter net sales were $1,359 million, reflecting a 1% decline year-over-year, falling short of the Zacks Consensus Estimate of $1,359.8 million [2] Financial Performance - Adjusted EBITDA rose 2% year-over-year to $179 million, driven by cost savings from the Titanium Technologies Transformation Plan and increased volumes in Thermal & Specialized Solutions [3] - For FY 2024, net sales totaled $5,782 million, a decline of 4.9% from the previous year, with adjusted net income dropping to $182 million from $425 million [7] - Cash provided by operating activities in Q4 2024 was $138 million, down from $482 million in the prior-year quarter [8] Segment Performance - The Titanium Technologies division reported revenues of $632 million, a 3% decrease from the previous year, primarily due to a 2% decrease in pricing and a 1% fall in volume [4] - The Thermal & Specialized Solutions segment saw a 3% year-over-year revenue increase to $390 million, driven by a 7% increase in volume, although it fell short of estimates [5] - Advanced Performance Materials revenues amounted to $324 million, a decline of approximately 1% year-over-year, primarily due to a 3% drop in price [6] Outlook - The company expects full-year 2025 adjusted EBITDA to be between $825 million and $975 million, with capital expenditures projected between $250 million and $300 million [10] Stock Performance - Chemours shares have decreased by 39.7% over the past year, contrasting with a 0.8% decline in the industry [11]

Core Points - The article discusses the investment positions held by the author in specific companies, indicating a beneficial long position in shares of CC and BASFY [1] - It emphasizes the importance of conducting due diligence and research before making any investment decisions, particularly in high-risk trading styles [2] - The article clarifies that past performance does not guarantee future results and that the views expressed may not reflect those of the platform as a whole [3] Summary by Categories - **Investment Positions** - The author has a beneficial long position in shares of CC and BASFY, either through stock ownership, options, or other derivatives [1] - **Investment Advice and Due Diligence** - The article stresses that it is not financial advice and that investors should perform their own due diligence and research prior to any investment [2] - It highlights the risks associated with short-term trading, options trading, and futures trading, which may not be suitable for investors with limited capital or experience [2] - **Performance and Opinions** - The article notes that past performance is not a guarantee of future results, and the opinions expressed may not represent the views of the platform as a whole [3]

Chemours (CC) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this chemical company would post earnings of $0.32 per share when it actually produced earnings of $0.40, delivering a surprise of 25%.Over the last four quarters, the company has su ...

Thermal & Specialized Solutions - The Thermal & Specialized Solutions segment is a leading global provider of refrigerants and thermal management solutions, with a focus on low GWP and sustainable technologies like Opteon™, which was commercialized in 2016[30] - In 2023, the company announced the initial commercialization of Opteon™ 2P50, targeted for the first half of 2026, to meet increasing demands for cooling capacities driven by advancements in AI and computing[31] - The company plans to expand Opteon™ YF capacity at its Corpus Christi, Texas facility by approximately 40% to meet customer needs transitioning to lower GWP refrigerants, with mechanical completion expected in Q4 2024[31] - The company has a leadership position in fluorine chemistry and materials science, competing against major players like Honeywell and Daikin in the Thermal & Specialized Solutions segment[32] - Chemours aims to achieve a goal of avoiding 325 million tons of carbon dioxide equivalent emissions globally by the end of 2025 through its low GWP products[86] Titanium Technologies - The Titanium Technologies segment has a nameplate capacity of approximately 1.1 million metric tons per year for TiO2 pigment, with production facilities in the U.S. and Mexico[40] - The Titanium Technologies Transformation Plan achieved approximately $190 million in cost savings, with $140 million related to 2024 and $50 million related to 2023, following the shutdown of the Kuan Yin facility in Taiwan[45] - The worldwide demand for TiO2 pigment in 2024 was estimated at approximately 7.3 million metric tons, with nameplate capacity at around 9.9 million metric tons[47] - The Titanium Technologies segment's raw materials include titanium-bearing ores, chlorine, and calcined petroleum coke, sourced from multiple suppliers to ensure supply chain flexibility[50] - In 2024, the top 10 customers in the Titanium Technologies segment represented about 41% of net sales, with one customer exceeding 10% of net sales[58] - TiO2 pigment sales volume is typically highest in the second and third quarters due to seasonality influenced by weather and holiday seasons[59] - The Titanium Technologies business focuses on sustainability with the Ti-Pure™ Sustainability product series, enhancing product sustainability designations[90] - Energy costs account for approximately 10% of the production cost in TiO2 pigment manufacturing, with access to low-cost natural gas in U.S. and Mexico facilities[54] Advanced Performance Materials - The Advanced Performance Materials segment serves around 1,000 customers globally, with no single customer accounting for more than 10% of net sales in 2024[71] - The Advanced Performance Materials segment is positioned for growth driven by demand for clean energy and advanced electronics technologies[64] - Chemours launched operations at THE Mobility F.C. Membranes Company in 2023 to enhance fuel cell and humidifier membrane manufacturing capacity[62] Environmental Commitment - Chemours aims for a 60% absolute reduction in greenhouse gas emissions by 2030 and a 25% reduction in Scope 3 emissions per ton of product by 2030[84] - The company has successfully reduced Scope 1 and Scope 2 GHG emissions by 60% and achieved a 99% reduction in air and water process emissions of fluorinated organic chemicals[87] - The company is subject to significant compliance costs related to environmental laws and regulations, which may increase over time[92] - The board of directors established an Environmental, Health, Safety, and Operations Performance committee to oversee environmental and safety risk management[102] Employee and Workforce Management - Chemours has approximately 6,000 employees globally, with 77% located in the Americas, 16% in Europe, and 7% in Asia Pacific[96] - The company reported a voluntary attrition percentage of approximately 8% for the year ended December 31, 2024, indicating effective employee retention strategies[108] - Chemours is committed to transparency in pay practices, having implemented measures to ensure equitable remuneration across its workforce[107] Financial Management and Risk - Chemours utilizes derivative financial instruments to manage risks associated with foreign currency exchange rates and commodity prices[498] - As of December 31, 2024, the company had 11 foreign currency forward contracts with a gross notional U.S. dollar equivalent of $196 million, resulting in a fair value of less than $1 million[501] - The company recognized a net gain of $5 million in 2024 from non-designated foreign currency forward contracts, compared to a net loss of $7 million in 2023[501] - Under the cash flow hedge program, the company had 173 foreign currency forward contracts with a notional U.S. dollar equivalent of $178 million and a fair value of $7 million as of December 31, 2024[502] - The company reported a pre-tax gain of $7 million in 2024 from cash flow hedges, compared to a pre-tax loss of $2 million in 2023[502] - The company designated euro-denominated debt as a hedge, recognizing a pre-tax gain of $47 million in 2024, following a pre-tax loss of $27 million in 2023[503] - The company entered into a cross-currency swap to convert $600 million of senior unsecured notes into €567 million, with a fair value of $5 million as of December 31, 2024[504] - The company had two interest rate swaps with a notional U.S. dollar equivalent of $300 million, resulting in a fair value of negative $3 million as of December 31, 2024[506] - A pre-tax gain of $9 million was recognized in 2024 from interest rate swaps, compared to a pre-tax loss of $6 million in 2023[506] - As of December 31, 2024, one customer represented approximately 7% of total accounts and notes receivable, indicating a diversified customer base[507] - The company did not have any commodity derivative financial instruments in place as of December 31, 2024 and 2023, indicating a strategy to manage commodity price risks through sales contracts[509]

Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 18, 2025, might help the stock move higher if these key numbers are better than expe ...